Maynard Um
-
-
-
-
-
-
-
Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens on PFS, OS Results
-
-
-
-
-
-
-
Increasing unusual option volume: CMPX IVZ BKLN UTHR KIE ORBS BMEA SGHC
-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)
-
-
-
-
-
-
-
Compass Therapeutics reports $209 million cash, appoints new executives
-
-
-
-
-
-
-
Citizens Starts Compass Therapeutics (CMPX) at Market Outperform
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
-
-
-
-
-
-
-
Compass Therapeutics, Inc (CMPX) Reports CTX-009 Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study
-
443,846 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

